ResMed develops and manufactures products for the diagnosis and treatment of sleep-disordered breathing, which affects about 20 percent of adults according to a 2002 study. Founded in 1989, the company maintains a focus on treating obstructive sleep apnea, the most common type of sleeping disorder. Products include masks, devices, airflow generators, humidifiers, portable screening and diagnostics and packages of combined equipment.
Home » ResMed
More recent news
- FDA says Medtronic can study Affera pulsed field ablation system for treating ventricular tachycardia
- Analysts see $400B BCI opportunity
- Endostart wins CE mark to bring magnetic balloon tech to enteroscopy
- Neurotech company CeriBell prices $180.3M IPO
- Astellas subsidiary Iota wins FDA IDE nod to study implantable bladder device